SMMTSummit TherapeuticsSigning up patients
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Metastatic Colorectal Cancer (CRC)
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 3
- Patients
- 900 (planned)
- Started
- Nov 18, 2025
- Main results expected
- May 31, 2028
- Fully finished
- Nov 30, 2029
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
PFS by IRRC based on RECIST v1.1
Measured over: Up to approximately 2.5 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT07228832 · record last updated 2026-11-05 · checked 2026-11-09 15:47 UTC